Invenomic Capital Management’s PRA Group PRAA Stock Holding History

Invenomic Capital Management’s Portfolio PRAA Stock Details PRAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-407,398	Closed	-$7.13M	–	147
2026 Q1	$7.13M	Sell	407,398 -19,978	-5%	-$304K	0.33%	80
2025 Q4	$7.56M	Buy	427,376 +11,895	+3%	+$185K	0.35%	89
2025 Q3	$6.42M	Buy	415,481 +53,068	+15%	+$859K	0.31%	89
2025 Q2	$5.35M	Buy	+362,413	New	+$5.77M	0.3%	98
2024 Q1	–	Sell	-220,228	Closed	-$5.77M	–	181
2023 Q4	$5.77M	Sell	220,228 -35,168	-14%	-$658K	0.26%	103
2023 Q3	$4.91M	Buy	255,396 +204,716	+404%	+$4.31M	0.21%	95
2023 Q2	$1.16M	Buy	+50,680	New	+$1.4M	0.06%	129

Other funds holding PRAA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invenomic Capital Management's PRAA Position: Q2 2026 in Review

Invenomic Capital Management sold out of PRA Group (PRAA) in Q2 2026, closing a stake of 407,398 shares — an estimated $7.13M sold.

Invenomic Capital Management first reported a position in PRAA in Q2 2023 and held it in 7 quarters. The position peaked at $7.56M in Q4 2025. 198 funds tracked by Wall St. Rank hold PRAA as of Q2 2026.

Invenomic Capital Management reported no remaining PRA Group position as of Q2 2026 after selling out during the quarter.
Invenomic Capital Management sold 407,398 PRA Group shares in Q2 2026, an estimated $7.13M.
Invenomic Capital Management first reported a position in PRA Group in Q2 2023 and held it in 7 quarters.
Invenomic Capital Management's PRA Group position peaked at $7.56M in Q4 2025.
198 funds tracked by Wall St. Rank held PRA Group as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.